Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 5, 2002, Pages 615-616

  Von Heymann, Christian ^a   Hotz, H ^a   Konertz, W ^a   Kox, W J ^a   Spies, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Coagulation; Coagulopathy; Coronary artery surgery; Postopertive bleeding; Recombinant factor VIIa; Reoperation

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BLOOD COMPONENT THERAPY; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HOMEOSTASIS; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0036795428     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.126927     Document Type: Article

References (11)

1. Boyle EM, Verrier ED, Spiess BD: The procoagulant response to injury. Ann Thorac Surg 64:16-23, 1997
2. Despotis GJ. Joist JH: Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass. J Cardiothorac Vasc Anesth 13:18-29, 1999 (4 suppl 1)
3. Dacey LJ, Munoz JJ, Baribeau YR, et al: Reexploration for hemorrhage following coronary artery bypass grafting. Arch Surg 133:442-447, 1998
4. Moulton MJ, Creswell LL, Mackey ME, et al: Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 111:1037-1046, 1996
5. Hedner U: NovoSeven as a universal haemostatic agent. Blood Coag Fibrinol 11:S107-S111, 2000 (suppl 1)
6. Al Douri M, Shafi T, Al Khudairi D. et al: Effect of the administration of recombinant activated factor VII (rFVIIa@: NovoSeven) in the treatment of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coag Fibrinol 11:121-127, 2001 (suppl 1)
7. Hendriks HGD, van der Maaten JMAA, de Wolf J, et al: An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 93:287-289, 2001
8. Hedner U, Erhardtsen E: Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI. Ann Med 32:68-72, 2000 (suppl 1)
9. Hoffman M, Monroe DM, Oliver JA, Roberts HR: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-547, 1997
10. van't Veer C, Mann KG: The regulation of the factor VII-dependent coagulation pathway: Rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost 26:367-372, 2000
11. Johanessen M, Nielsen G, Nordfang O: Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven). Blood Coag Fibrinol 11:S159-S 164, 2001 (suppl 1)